Great Moments in Warped Public Perception

56 Comments

I realize ESPN reader polls aren’t scientific, but check this one out:

source:

Baseball’s confrontation with PEDs has been long and loud and public. It’s the sport where people get hung up on the integrity of the record book way more than any other and where people get hung up on their relationship with the sport as a child more than any other, looking for heroes and purity and wallowing in more nostalgia.  Most importantly, in recent years, baseball has also had the most rigorous testing and enforcement program of all the major sports, leading to more positives, more discipline and more news stories. In light of that I understand how one might be tricked into thinking that baseball has the most widespread drug use.

That said: for people to actually think that that baseball has a bigger PED problem than football, and by such margins, is flippin’ crazypants.

This is the hidden data problem, or some variation of it, in action. We see things when they happen. We don’t see things when they don’t happen. We don’t see NFL players get busted for PEDs, so they must not be taking them, the thinking goes.

Angels sign Zack Cozart to a three-year, $38 million deal

Getty Images
3 Comments

Ken Rosenthal reports that the Angels have signed infielder Zack Cozart to a three-year, $38 million deal.

That seems like a bargain deal for Cozart, who hit .297/.385/.548 with 24 homers and 63 RBI as the Cincinnati Reds shortstop in 2017. In Anaheim, however, he will not be playing short — not with Andrelton Simmons around — so he’ll slide over to third base. He’s never played there, but you figure he can handle it.

This is a pretty nifty move for the Angels, as the other top third base options — specifically, Mike Moustakas — are likely going to cost a lot more than what they’ll be paying Cozart.

Between this, the Ian Kinsler trade and the Shohei Ohtani acquisition, the Angels are going to be sporting a very different look in 2018.